Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.

about

Differential Proteomic Analysis of Dimethylnitrosamine (DMN)-Induced Liver Fibrosis.

P2860

Q47658920-C9D2D74E-88F7-4DEA-A726-D03E03AA71EF

P2860

Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.

Item

http://www.wikidata.org/entity/Q39732824

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.

@en

Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.

@nl

type

Item

label

Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.

@en

Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.

@nl

prefLabel

Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.

@en

Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.

@nl

P1476

Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.

@en

P2093

Denise Oró

http://www.w3.org/2001/XMLSchema#string

Guillermo Fernández-Varo

http://www.w3.org/2001/XMLSchema#string

Santiago Marfà

http://www.w3.org/2001/XMLSchema#string

P2860

Casein kinase I phosphorylates and destabilizes the beta-catenin degradation complex

The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation

Regulation of casein kinase I epsilon activity by Wnt signaling

Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice

Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis

Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation

limma powers differential expression analyses for RNA-sequencing and microarray studies

Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors

Proteomics in early detection of cancer.

Proteomic approaches to biomarker discovery in prostate and bladder cancers.

P304

858-865

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1242/BIO.018887

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Manuel Morales-Ruiz

Wladimiro Jiménez

Jordi Ribera

P577

2016-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27230648

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

4920198

http://www.w3.org/2001/XMLSchema#string

Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.

about

P2860

P2860

Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932